This Award is intended for Canadian clinical trainees (PGY 4-6) for a research project on any topic related to thrombosis, anticoagulation, stroke, or atrial fibrillation.
The program is particularly interested in research that has the potential to advance knowledge about or improve the care of patients at risk for vascular, thrombotic or embolic events.
Three awards totalling up to $45,000 will be awarded based on an independent peer review process. A bonus award of $5,000 will be awarded by the CCC session audience to one of the three finalists for the most effective and persuasive presentation. Funded research must be completed within 48 months from the start of funding.
- Applicants must be enrolled in a Canadian clinical training program (PGY 4-6) for, but not limited to, adult or pediatric cardiology, cardiac or vascular surgery.
- Must be a CCS Member. For more information about CCS Membership, visit the CCS website
- Funds are intended for Canadian Research purposes
- Applicants must be available to travel to Montreal to present their research projects to the judging panel during a session at the Canadian Cardiovascular Congress (CCC), on October 26, 2019. Finalists will be provided a complimentary registration to attend the CCC.
Important Dates & Deadlines:
- Submission Deadline: September 9, 2019.
- Finalists Announcement: Late September 2019.
- Award Presented: October 26, 2019.
- 1st prize: $20,000
- 2nd prize: $15,000
- 3rd prize: $10,000
An additional $5,000 prize to be awarded by the CCC session audience to one of the three finalists for the most effective and persuasive presentation.
Funds will be administered by the Cardiology Division of the awardees affiliated university or equivalent.
Terms of Reference and submission guidelines:
Applicants are asked to submit a proposal, including the following:
- Project Abstract. Max 400 words
- Outline of the project. Is the project part of a larger study or grant? If so, please explain.
- Description of the research environment. Where will the research project will be conducted? (research must be conducted in Canada)
- If the scope of the project is greater than the funds awarded, the applicant must explain what area the grant will be used in. If other member(s) of the team is/are involved in the project, applicant is to describe his/her role in the study.
- Budget - Is the project partially funded using other channels? If so, please explain. As an attachment, template provided below.
- A brief 1-page curriculum vitae outlining any prior research experience and publications. As an attachment.
- Hi-resolution photo
- Name of mentor or supervisor
- Name and contact information of Institution and individual who will receive the funds
An evaluation committee chaired by Dr. Jeff Healey and consisting of Drs. Katia Dyrda, Jean-François Tanguay, Rob Welsh, Richard Whitlock, and, Lena Rivard will review all applications and select the three most meritorious finalists.
Evaluation of applications will be based on three criteria quality and feasibility of project, quality of applicant, research environment and mentor.
These three finalists will present their research project at a session held during the Canadian Cardiovascular Congress (CCC) in Montreal, on October 26, 2019. During a 10-minute presentation, they will have the opportunity to present the research project and answer questions from the judging panel above.
Following the three presentations, each of the three finalists will be awarded a Vascular Award.
The Canadian Cardiovascular Society and Bayer Inc. are proud to support the CCS-Bayer Resident Vascular Award. With this award, we hope to further research in thrombosis, anticoagulation, stroke, or atrial fibrillation to improve the lives of Canadians who are affected by these conditions, and their families.